Cynvenio Biosystems, Inc.

Cynvenio Biosystems, Inc. is a leader in the development of more affordable and clinically actionable precision medicine strategies for the individual cancer patient. Focused on rapid advancement in the molecular biology field, Cynvenio’s genomic tests accurately target known mutations in cancer-related genes to revolutionize personalized treatment decision making and clinical trial selection. Among its breakthroughs is an expanding line of ClearID® tests engineered for greatly improved cancer detection and monitoring via a patient-friendly blood draw, and proprietary LiquidBiopsy® technology that makes real-time molecular characterization from whole blood a reality. Cynvenio is based in Westlake Village, CA (Los Angeles). Cynvenio is headquartered in Westlake Village, California (Los Angeles). For more information, visit http://www.cynvenio.com.